Sporos Bioventures LLC - 15 Apr 2025 SCHEDULE 13G Report for Tvardi Therapeutics, Inc. Common Stock, par value $0.001 per share (CARA)

Filing Manager: Sporos Bioventures LLC
Reporting Manager: Sporos Bioventures LLC
Security: Tvardi Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: CARA
Shares outstanding: 9.36M shares
Disclosed Ownership: 838K shares
Ownership: 8.95%
Form type: SCHEDULE 13G
Filing time: 08 Aug 2025, 16:30:09 UTC
Date of event: 15 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Sporos Bioventures LLC	8.95%	838K	838K	0	/s/ Stephen Rubino	Stephen Rubino, Chief Executive Officer